Scaling Success: Hanley Energy’s Journey From Ireland to the U.S.
Forming friendships, cross border referrals and mentoring with Paul Beare
Compliance Tip of the Day: Cross Border Investigations, Part 1
JONES DAY PRESENTS®: Cross-Border Trade Secret Litigation in the United States
AGG Talks: Cross-Border Business - Navigating Business Etiquette and Intercultural Communications Around the Globe
Garnishment Practices: Has the Dust Settled or Is It Still Flying? — The Consumer Finance Podcast
The Standard Formula Podcast | Solvency II Back to Basics: Third Country Branches and Cross-Border Provision of Services
La caída de las normas especiales de insolvencia
Strategy Considerations for Global Litigation
Chapter 15 Bankruptcy Issues, Venue, and Jurisdiction by Kristhy Peguero and Jennifer Wertz
Viewpoints: President José María Aznar Examines Economic Landscape in Latin America
Podcast: International Risks Facing Latin America Companies
One Month to Better Investigations and Reporting-Day 10-Best Practices in a Cross-Border Investigation
FCPA Compliance and Ethics Report-Episode 167-Mara Senn on the Top 10 Practices in a Cross-Border Investigation
FCPA Compliance and Ethics Report-Episode 110-interview with Jonathan Armstrong
Cross-Border Update on Investing and Doing Business in the United States
Cross-Border Regulation of Swaps Update from ISDA's Robert Pickel (Part 1)
Barbara Knoflach, CEO of SEB Asset Management, on the rise of cross-border real estate investment
License to travel: how regulation is benefiting business abroad
Global Dealmaking in 2013: Why the Best Strategies will Dominate
Explore skinny labelling & obviousness in Canada and Australia - If you are an intellectual property (IP) owner, a litigator or an in-house legal professional managing IP litigation in multiple jurisdictions, don’t miss...more
Hosted by the American Conference Institute, the 19th Annual FCPA & Anti-Corruption Conference for the Life Sciences Industry returns for another exciting year with carefully researched programming based on critical findings...more
Against the backdrop of a slower M&A market, collaborations between biotech companies and pharma companies have remained robust, particularly those focusing on innovation and collaboration for value creation. According to a...more
Dealmaking in the pharma, medical and biotech (PMB) subsectors was driven by both old and new market trends in 2022 - Following a ground-breaking year for dealmaking in 2021, global healthcare M&A remained robust in 2022,...more
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more
By Ministerial Circular of 23 March 2017, AIFA clarified the conditions under which unauthorized medicinal products may be purchased abroad further to the procedure laid down by the Ministerial Decree of 11 February 1997....more
Alien Tort Statute (ATS)/Torture Victims Protection Act (TVPA)/Anti-Terrorism Act (ATA) - District Court Dismisses ATS Claim Where Alleged Conduct in US Was Not Directly Linked to Injuries Claimed in Other Countries - ...more
In Actavis Group HF v. Eli Lilly & Co. the UK High Court has granted a declaration of non-infringement in the UK, France, Italy and Spain. A jurisdictional challenge in relation to the French, Italian and Spanish...more
As Congress Seeks Additional Funding, Inversion Proposal Emerges - Throughout the past several weeks, Pfizer’s attempt to acquire AstraZeneca has garnered significant congressional and media attention. Pfizer, a U.S....more
New legal ground is expected to be broken this year in areas of importance to companies and their directors, officers and executives. We see those developments coming from around the globe and defining the litigation...more